FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976903473> ?p ?o ?g. }

• W1976903473 endingPage "876" @default.
• W1976903473 startingPage "867" @default.
• W1976903473 abstract "Purpose To study whether radiation induces differential changes in plasma proteomics in patients with and without radiation-induced lung toxicity (RILT) of Grade ≥2 (RILT2). Methods and Materials A total of 57 patients with NSCLC received radiation therapy (RT) were eligible. Twenty patients, 6 with RILT2 with tumor stage matched to 14 without RILT2, were enrolled for this analysis. Platelet-poor plasma was obtained before RT, at 2, 4, 6 weeks during RT, and 1 and 3 months after RT. Plasma proteomes were compared using a multiplexed quantitative proteomics approach involving ExacTag labeling, reverse-phase high-performance liquid chromatography and nano-LC electrospray tandem mass spectrometry. Variance components models were used to identify the differential protein expression between patients with and without RILT2. Results More than 100 proteins were identified and quantified. After excluding proteins for which there were not at least 2 subjects with data for at least two time points, 76 proteins remained for this preliminary analysis. C4b-binding protein alpha chain, Complement C3, and Vitronectin had significantly higher expression levels in patients with RILT2 compared with patients without RILT2, based on both the data sets of RT start to 3 months post-RT (p < 0.01) and RT start to the end of RT (p < 0.01). The expression ratios of patients with RILT2 vs. without RILT2 were 1.60, 1.36, 1.46, and 1.66, 1.34, 1.46, for the above three proteins, respectively. Conclusions This proteomic approach identified new plasma protein markers for future studies on RILT prediction. To study whether radiation induces differential changes in plasma proteomics in patients with and without radiation-induced lung toxicity (RILT) of Grade ≥2 (RILT2). A total of 57 patients with NSCLC received radiation therapy (RT) were eligible. Twenty patients, 6 with RILT2 with tumor stage matched to 14 without RILT2, were enrolled for this analysis. Platelet-poor plasma was obtained before RT, at 2, 4, 6 weeks during RT, and 1 and 3 months after RT. Plasma proteomes were compared using a multiplexed quantitative proteomics approach involving ExacTag labeling, reverse-phase high-performance liquid chromatography and nano-LC electrospray tandem mass spectrometry. Variance components models were used to identify the differential protein expression between patients with and without RILT2. More than 100 proteins were identified and quantified. After excluding proteins for which there were not at least 2 subjects with data for at least two time points, 76 proteins remained for this preliminary analysis. C4b-binding protein alpha chain, Complement C3, and Vitronectin had significantly higher expression levels in patients with RILT2 compared with patients without RILT2, based on both the data sets of RT start to 3 months post-RT (p < 0.01) and RT start to the end of RT (p < 0.01). The expression ratios of patients with RILT2 vs. without RILT2 were 1.60, 1.36, 1.46, and 1.66, 1.34, 1.46, for the above three proteins, respectively. This proteomic approach identified new plasma protein markers for future studies on RILT prediction." @default.
• W1976903473 created "2016-06-24" @default.
• W1976903473 creator A5012072077 @default.
• W1976903473 creator A5013706483 @default.
• W1976903473 creator A5024145033 @default.
• W1976903473 creator A5032956681 @default.
• W1976903473 creator A5046132413 @default.
• W1976903473 creator A5047138511 @default.
• W1976903473 creator A5074120071 @default.
• W1976903473 creator A5087107933 @default.
• W1976903473 date "2010-07-01" @default.
• W1976903473 modified "2023-10-09" @default.
• W1976903473 title "Plasma Proteomic Analysis May Identify New Markers for Radiation-Induced Lung Toxicity in Patients With Non–Small-Cell Lung Cancer" @default.
• W1976903473 cites W1924115225 @default.
• W1976903473 cites W1964064441 @default.
• W1976903473 cites W1967431359 @default.
• W1976903473 cites W1970953269 @default.
• W1976903473 cites W1973474133 @default.
• W1976903473 cites W1976915157 @default.
• W1976903473 cites W1979281407 @default.
• W1976903473 cites W1980548993 @default.
• W1976903473 cites W1999600269 @default.
• W1976903473 cites W2002843629 @default.
• W1976903473 cites W2004872627 @default.
• W1976903473 cites W2015556811 @default.
• W1976903473 cites W2021532280 @default.
• W1976903473 cites W2029175519 @default.
• W1976903473 cites W2032393507 @default.
• W1976903473 cites W2039738824 @default.
• W1976903473 cites W2043103956 @default.
• W1976903473 cites W2044483798 @default.
• W1976903473 cites W2049381037 @default.
• W1976903473 cites W2050850257 @default.
• W1976903473 cites W2052217082 @default.
• W1976903473 cites W2059589551 @default.
• W1976903473 cites W2061379116 @default.
• W1976903473 cites W2061567983 @default.
• W1976903473 cites W2061802061 @default.
• W1976903473 cites W2074747582 @default.
• W1976903473 cites W2080029544 @default.
• W1976903473 cites W2080705343 @default.
• W1976903473 cites W2081444591 @default.
• W1976903473 cites W2091933198 @default.
• W1976903473 cites W2092086565 @default.
• W1976903473 cites W2094011295 @default.
• W1976903473 cites W2097937744 @default.
• W1976903473 cites W2107312689 @default.
• W1976903473 cites W2108154223 @default.
• W1976903473 cites W2108228282 @default.
• W1976903473 cites W2111208057 @default.
• W1976903473 cites W2112455601 @default.
• W1976903473 cites W2115944658 @default.
• W1976903473 cites W2116910713 @default.
• W1976903473 cites W2120454971 @default.
• W1976903473 cites W2132592568 @default.
• W1976903473 cites W2137082708 @default.
• W1976903473 cites W2139362414 @default.
• W1976903473 cites W2140946052 @default.
• W1976903473 cites W2145061443 @default.
• W1976903473 cites W2146743941 @default.
• W1976903473 cites W2150160398 @default.
• W1976903473 cites W2160726712 @default.
• W1976903473 cites W2170527066 @default.
• W1976903473 cites W2336513514 @default.
• W1976903473 cites W4297846773 @default.
• W1976903473 doi "https://doi.org/10.1016/j.ijrobp.2010.01.038" @default.
• W1976903473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20510197" @default.
• W1976903473 hasPublicationYear "2010" @default.
• W1976903473 type Work @default.
• W1976903473 sameAs 1976903473 @default.
• W1976903473 citedByCount "33" @default.
• W1976903473 countsByYear W19769034732012 @default.
• W1976903473 countsByYear W19769034732013 @default.
• W1976903473 countsByYear W19769034732014 @default.
• W1976903473 countsByYear W19769034732015 @default.
• W1976903473 countsByYear W19769034732016 @default.
• W1976903473 countsByYear W19769034732017 @default.
• W1976903473 countsByYear W19769034732019 @default.
• W1976903473 countsByYear W19769034732020 @default.
• W1976903473 countsByYear W19769034732021 @default.
• W1976903473 crossrefType "journal-article" @default.
• W1976903473 hasAuthorship W1976903473A5012072077 @default.
• W1976903473 hasAuthorship W1976903473A5013706483 @default.
• W1976903473 hasAuthorship W1976903473A5024145033 @default.
• W1976903473 hasAuthorship W1976903473A5032956681 @default.
• W1976903473 hasAuthorship W1976903473A5046132413 @default.
• W1976903473 hasAuthorship W1976903473A5047138511 @default.
• W1976903473 hasAuthorship W1976903473A5074120071 @default.
• W1976903473 hasAuthorship W1976903473A5087107933 @default.
• W1976903473 hasConcept C104317684 @default.
• W1976903473 hasConcept C104397665 @default.
• W1976903473 hasConcept C126322002 @default.
• W1976903473 hasConcept C142724271 @default.
• W1976903473 hasConcept C143998085 @default.
• W1976903473 hasConcept C146543888 @default.
• W1976903473 hasConcept C162356407 @default.
• W1976903473 hasConcept C185592680 @default.
• W1976903473 hasConcept C2776256026 @default.

• next